Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.18 +0.33 (+1.18%)
Official Closing Price Updated: 4:10 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,796,222
Open 27.76
Bid (Size) 28.16 (1)
Ask (Size) 28.18 (10)
Prev. Close 27.85
Today's Range 27.32 - 28.25
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.82%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Via Benzinga
3 Profitable Dividend Stocks to Buy at Near-Lows
With high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety. 
Via InvestorPlace

Performance

YTD
-5.21%
-5.21%
1 Month
+6.02%
+6.02%
3 Month
+2.25%
+2.25%
6 Month
-8.57%
-8.57%
1 Year
-26.77%
-26.77%

More News

Read More
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
Via InvestorPlace
2 No-Brainer Dividend Stocks to Buy in May
Via The Motley Fool
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Via The Motley Fool
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
Via Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Via InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Via FinancialNewsMedia
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
Via Benzinga
Topics Economy
Exposures Economy
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
Tuesday Talk: Still Flying
Via Talk Markets
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
Via InvestorPlace
What's Going With BioNTech Stock On Monday?
Via Benzinga
Pfizer Announces New Chief Strategy and Innovation Officer
From Pfizer Inc.
Via Business Wire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Via MarketBeat
Exposures COVID-19
How this baseball All-Star steps up to the plate when it comes to pneumococcal pneumonia
Via Brandpoint
Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth
Via InvestorPlace
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.